Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
6.80
-0.07 (-1.02%)
Sep 18, 2025, 2:45 PM CST
SHE:002252 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 1,982 | 2,193 | 1,779 | 1,880 | 1,295 | 1,324 | Upgrade |
Depreciation & Amortization | 186.44 | 201.43 | 163 | 184.98 | 159.27 | 152.76 | Upgrade |
Other Amortization | 18 | 16 | 9.5 | 9.94 | 9.55 | 11.25 | Upgrade |
Loss (Gain) From Sale of Assets | 0.4 | 1.61 | 0.01 | -0.23 | 1.35 | -0.97 | Upgrade |
Asset Writedown & Restructuring Costs | 9.79 | 13.23 | 4.31 | 199.5 | 370.45 | 132.51 | Upgrade |
Loss (Gain) From Sale of Investments | -370.08 | -513.51 | 196.89 | -430.77 | 42.76 | -537.65 | Upgrade |
Stock-Based Compensation | 53.78 | 53.78 | 21.61 | - | - | - | Upgrade |
Provision & Write-off of Bad Debts | 52.19 | 42.98 | -5.22 | 16.38 | -10.83 | 3.95 | Upgrade |
Other Operating Activities | -78.04 | -87.48 | -89.3 | -94.55 | -435.77 | -9.38 | Upgrade |
Change in Accounts Receivable | -1,439 | -1,229 | 163.23 | -286.97 | -75.16 | 253.86 | Upgrade |
Change in Inventory | -647.92 | -638.98 | -417.74 | -106.32 | -1,014 | -259.26 | Upgrade |
Change in Accounts Payable | 506.76 | -542.72 | 449.23 | 333.94 | 961.09 | 24.96 | Upgrade |
Operating Cash Flow | 304.75 | -482.06 | 2,278 | 1,726 | 1,294 | 1,169 | Upgrade |
Operating Cash Flow Growth | -61.76% | - | 32.01% | 33.35% | 10.71% | 33.93% | Upgrade |
Capital Expenditures | -318.12 | -407.15 | -450.8 | -225.73 | -204.61 | -251.76 | Upgrade |
Sale of Property, Plant & Equipment | 0.34 | 0.33 | 2.33 | 2.24 | 3.19 | 9.03 | Upgrade |
Cash Acquisitions | -3,738 | -34 | -440.69 | - | - | - | Upgrade |
Investment in Securities | 956.89 | -775.21 | 141.72 | -946.68 | -609.51 | -373.01 | Upgrade |
Other Investing Activities | 262.24 | 300.11 | 76.84 | 39.97 | 80.11 | 7.02 | Upgrade |
Investing Cash Flow | -2,837 | -915.92 | -670.59 | -1,130 | -730.82 | -608.73 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 7.74 | Upgrade |
Total Debt Issued | 2,533 | - | - | - | - | 7.74 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | -7.74 | - | Upgrade |
Long-Term Debt Repaid | - | -4.65 | -2.04 | -5.73 | -4.21 | - | Upgrade |
Total Debt Repaid | -26.72 | -4.65 | -2.04 | -5.73 | -11.95 | - | Upgrade |
Net Debt Issued (Repaid) | 2,506 | -4.65 | -2.04 | -5.73 | -11.95 | 7.74 | Upgrade |
Issuance of Common Stock | 15.57 | 15.57 | 113.17 | - | - | - | Upgrade |
Repurchase of Common Stock | -351.32 | -2.27 | -1,000 | - | - | - | Upgrade |
Common Dividends Paid | -247.79 | -439.85 | -202.22 | -188.74 | -168.52 | -67.78 | Upgrade |
Other Financing Activities | 0.22 | -33.2 | -43.13 | 1.09 | 1.19 | 1.19 | Upgrade |
Financing Cash Flow | 1,923 | -464.41 | -1,134 | -193.38 | -179.28 | -58.84 | Upgrade |
Foreign Exchange Rate Adjustments | 0.97 | 1.32 | -3.31 | 11.75 | -2.26 | -4.76 | Upgrade |
Net Cash Flow | -608.08 | -1,861 | 469.77 | 413.78 | 381.66 | 496.51 | Upgrade |
Free Cash Flow | -13.37 | -889.2 | 1,827 | 1,500 | 1,089 | 917.09 | Upgrade |
Free Cash Flow Growth | - | - | 21.82% | 37.68% | 18.79% | 27.76% | Upgrade |
Free Cash Flow Margin | -0.17% | -10.88% | 22.94% | 22.84% | 25.41% | 33.21% | Upgrade |
Free Cash Flow Per Share | -0.00 | -0.13 | 0.28 | 0.22 | 0.16 | 0.14 | Upgrade |
Cash Interest Paid | - | - | - | - | 0.03 | - | Upgrade |
Cash Income Tax Paid | 649.35 | 825.58 | 644.74 | 593.92 | 339.12 | 220.76 | Upgrade |
Levered Free Cash Flow | -357.83 | -1,223 | 1,594 | 1,180 | 748.69 | 564.79 | Upgrade |
Unlevered Free Cash Flow | -353.98 | -1,223 | 1,594 | 1,180 | 748.99 | 565.03 | Upgrade |
Change in Working Capital | -1,550 | -2,403 | 197.6 | -39.73 | -137.29 | 92.68 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.